Based on the variety in the mechanisms of PTP1B inhibitors, an enormous number of novel molecules has been designed and synthesized in the past 6 years, highlighting the importance of PTP1B in the treatment of type-II diabetes. The gene discussed is PTPN1; the disease is type 2 diabetes mellitus.